Parexel · 1 day ago
Scientist III - Regulated Immunogenicity & Molecular Bioanalytics - FSP
Parexel is a company that provides pharmaceutical and biopharmaceutical companies with qualified technical professionals. They are seeking a Scientist III to work on generating quality experimental data and collaborating on method development in a regulated lab environment.
Pharmaceuticals
Responsibilities
Ability to generate quality experimental data
Communicates results and provides unsolicited ideas to team and project lead through meetings and in reports
Provide input as a collaborating scientist on method development reports and test method optimization, qualification and validation
Strong organizational and project management skills
Demonstrates urgency and sensitive to meet project timelines
Qualification
Required
Experience executing routine molecular assays, data interpretation, and quality control techniques for technologies including nucleic acid extraction, qPCR/dPCR, and NGS (Illumina platform)
Ability to follow established procedures, and strong attention to detail
Strong verbal and written communication skills with the ability to deliver ideas to an interdisciplinary team
Proven experience thinking critically and ability to solve complex technical issues
Competent individual that maintains full accountability for data generated and can work collaboratively in an organized setting
Proficient in the use of Microsoft Office, and electronic laboratory notebooks
Scientist 3: B.S./B.A. 3-5 years of experience or MS 1-2 years of experience
Preferred
Experience with GxP and working in a regulated lab environment
Familiarity with use of automation to generate data, perform data analysis, and notebook tracking to support test method execution
Troubleshooting and reworking experiments based on data interpretation
Experience analyzing and interpreting large data sets
Benefits
Full benefits
Sick time
401K
Paid holidays
Paid time off
Company
Parexel
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster.
Funding
Current Stage
Late StageLeadership Team
Recent News
2024-04-27
2024-04-07
Company data provided by crunchbase